3.0.0 1922 2026-02-13T21:03:05Z 2026-02-13T21:03:05Z House H HR 2025-03-06 119 https://www.congress.gov/bill/119th-congress/house-bill/1922 <pre>[Congressional Record Volume 171, Number 43 (Thursday, March 6, 2025)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Mr. GARBARINO:H.R. 1922.Congress has the power to enact this legislation pursuantto the following:Art. 1, Sec. 8.[Page H1039]</pre> hswm00 Ways and Means Committee House Standing Referred To 2025-03-06T14:01:45Z hsif00 Energy and Commerce Committee House Standing Referred To 2025-03-06T14:01:40Z 2025-03-06 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2025-03-06 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2025-03-06 Introduced in House IntroReferral Intro-H 9 Library of Congress 2025-03-06 Introduced in House IntroReferral 1000 9 Library of Congress G000597 Rep. Garbarino, Andrew R. [R-NY-2] Andrew Garbarino R NY R. 2 N H001086 Rep. Harshbarger, Diana [R-TN-1] Diana Harshbarger R TN 1 2025-03-06 True S001201 Rep. Suozzi, Thomas R. [D-NY-3] Thomas Suozzi D NY R. 3 2025-03-06 True Health Health 2025-03-21T18:28:55Z

00 2025-03-06 Introduced in House 2026-02-13T21:02:02Z <p><strong>Ensuring Access to Essential Drugs Act</strong></p><p>This bill exempts certain brand-name drugs from the Medicare Part D Manufacturer Discount Program. Under the program, drug manufacturers provide discounts to beneficiaries who have incurred costs above the annual deductible under the Medicare prescription drug benefit.</p><p>Specifically, the bill exempts from the program orally administered, brand-name drugs that are considered generics for purposes of the Medicaid Drug Rebate Program (per an exception granted by the Centers for Medicare &amp; Medicaid Services).</p>

Display Title 45 2025-03-21T04:38:24Z Short Title(s) as Introduced 101 2025-03-21T04:38:21Z Introduced in House IH Official Title as Introduced 6 2025-03-21T04:33:59Z Introduced in House IH Introduced in House 2025-03-06T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-119hr1922ih/xml/BILLS-119hr1922ih.xml 2025-03-06 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.